SURVYR

IQV

IQVIA Holdings Inc.
$271.55
−$2.05 (0.75%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-29%-15%0%+14%+28%Oct 2025Oct 2026Apr 202652w high $277.4052w low $154.50
IQVSPY
Wall St. Highest PT $345.00 (+27.0%) Wall St. Avg PT $300.95 (+10.8%)
$157$206$256$306$355POC $170Hi $345Avg $301
Underwater Drawdown %Max DD -35.9%Current -2.8%
0.0%-35.9%
Relative Strength vs SPY+11.4% vs SPYOutperforming
+41%0%-41%
1W
+$3.70 (1.38%)
1M
+$1.18 (0.44%)
3M
+$28.61 (11.78%)
6M
+$112.57 (70.81%)
YTD
+$46.14 (20.47%)
1Y
+$54.12 (24.89%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Strong Buy
19 analysts · mean score 1.41
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$271.55
Average target$300.95
+$29.40 (+10.8%) upsideaverage target vs current price
CurrentAverageMedian
Low$268.00
Median$300.95
High$345.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$45.5B
P/E (last 12 months)34.4
P/E (next 12 months, estimated)19.2
52-week range$154.50 – $277.40
Revenue growth (latest quarter vs a year ago)+8.7%
Dividend yieldNo dividend
Analyst consensusStrong Buy (19)
Average analyst price target$300.95 (+11%)

What they do

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Healthcare · Diagnostics & Research
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
58th percentile in sector
B-
12-1 return: +24.2%
Percentile within its GICS sector across the S&P 1500.
Growth
51st percentile in sector
C+
Revenue growth (YoY): +8.7%
Percentile within its GICS sector across the S&P 1500.
Value
40th percentile in sector
C-
Forward E/P: 5.4% · EBITDA/EV: 5.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
65th percentile in sector
B
Profit margin: +8.1% · Return on equity: +22.8%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 108 of 499 · 12-month momentum 37.5%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

IQV earningsNo upcoming date on file
Last 4 quarters · EPS vs estimate
Jul 28, 2026$3.15est $3.03+3.9%Above estimates
May 5, 2026$2.90est $2.82+3.0%Above estimates
Feb 5, 2026$3.42est $3.40+0.7%In line with estimates
Oct 28, 2025$3.00est $2.98+0.8%In line with estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-26 18:36:58 ET
24-1025-0225-0525-0725-1026-0226-0526-070.003.42
EstimateActual (beat)Actual (miss)

News & catalysts

More news
Artificial Intelligence (AI)-Driven Drug Safety and Pharmacovigilance Platforms Market Report 2026 | Capitalize on 20.2% CAGR with Microsoft, IBM, Oracle, IQVIA, and Veeva
GlobeNewswire · 9h ago
IQVIA (IQV) Q3 2026 Earnings Call Transcript
Nasdaq · 12h ago
IQVIA Holdings Q3 26 Earnings Conference Call At 9:00 AM ET
Nasdaq · 18h ago
IQVIA Holdings Boosts FY26 Outlook - Update
Nasdaq · 19h ago
IQVIA (IQV) files 8-K: results
SEC 8-K · 19h ago
Insider trades
Berkshire James G.
See Remarks · 2026-09-02
Sell
$697.2K
Staub W Richard
See Remarks · 2026-08-03
Sell
$1.3M
Patel Bhavik
See Remarks · 2026-07-31
Sell
$436.4K
Bousbib Ari
Director, See Remarks · 2026-07-29
Sell
$13.0M
Bousbib Ari
Director, See Remarks · 2026-07-29
Sell
$10.8M
Bousbib Ari
Director, See Remarks · 2026-07-29
Sell
$1.1M
Bousbib Ari
Director, See Remarks · 2026-07-29
Sell
$1.1M
Cherofsky Keriann
See Remarks · 2026-07-29
Sell
$136.8K
Sherbet Eric
See Remarks · 2026-07-29
Sell
$1.2M

Stats refreshed 2026-10-26 18:36:58 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026